Coherus Oncology, Inc. (CHRS): Cash & Equivalents
$88.88M
As of 2025-12-31
$82.92M
As of 2026-06-30
+11.8%
3-year compound annual growth
-30.3%
5-year compound annual growth
-5.6%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $88.88M | -29.5% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $125.99M | +22.4% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $102.89M | +61.9% | 2025-03-17, Balance as of period end |
| 2022-12-31 | $63.55M | -84.8% | 2025-03-17, Balance as of period end |
| 2021-12-31 | $417.19M | -22.9% | 2024-03-15, Balance as of period end |
| 2020-12-31 | $541.16M | +204.6% | 2023-03-06, Balance as of period end |
| 2019-12-31 | $177.67M | +145.5% | 2022-02-23, Balance as of period end |
| 2018-12-31 | $72.36M | -43.0% | 2021-02-25, Balance as of period end |
| 2017-12-31 | $126.91M | +1.6% | 2020-02-27, Balance as of period end |
| 2016-12-31 | $124.95M | -21.0% | 2018-03-08, Balance as of period end |
| 2015-12-31 | $158.23M | +5.2% | 2018-03-08, Balance as of period end |
| 2014-12-31 | $150.39M | +280.2% | 2017-03-14, Balance as of period end |
| 2013-12-31 | $39.55M | +171.9% | 2016-02-29, Balance as of period end |
| 2012-12-31 | $14.55M | n/a | 2015-03-23, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | 2025-12-31 | $88.88M | -29.5% |
| Tectonic Therapeutic, Inc. (TECX) | 2025-12-31 | $253.80M | +79.7% |
| Voyager Therapeutics, Inc. (VYGR) | 2025-12-31 | $65.30M | -8.5% |
| Lexeo Therapeutics, Inc. (LXEO) | 2025-12-31 | $63.00M | +79.9% |
| Adaptimmune Therapeutics PLC (ADAPY) | 2024-12-31 | $91.14M | -36.7% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $65.93M | -36.4% |
| Invivyd, Inc. (IVVD) | 2025-12-31 | $226.69M | +226.9% |
| DBV Technologies S.A. (DBVT) | 2025-12-31 | $194.17M | +498.2% |
| Solid Biosciences Inc. (SLDB) | 2025-12-31 | $59.90M | -25.3% |
Compare CHRS, TECX, VYGR, LXEO side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗